NVMI:TASENova Ltd. Analysis
Data as of 2026-05-22 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
The stock is trading at $496.5, comfortably above the computed support level of $462.77 yet still 12% below the identified resistance of $565, indicating room for upside if momentum sustains.
Technical gauges show a bullish trend direction with volume accelerating, but the MACD bearish signal and a neutral RSI of 48.9 temper short‑term optimism.
Fundamentally, Nova Ltd. delivers robust profitability—gross margin of 57.3%, operating margin of 30.1% and profit margin of 29.2%—and a 10.3% revenue growth rate, underscoring strong operating performance.
However, valuation metrics flag concerns: a trailing PE of 62.1 far exceeds the industry average of 39.1, a price‑to‑book of 12×, and a debt‑to‑equity of 57.7×, all of which inflate systematic and financial risk.
Risk indicators are pronounced: beta of 2.6 and 30‑day volatility near 61% suggest heightened market sensitivity, while a max drawdown of –21.6% reflects downside vulnerability.
Given this mix of bullish price action, solid earnings, but elevated valuation and leverage, the short‑term stance leans toward hold pending clearer momentum, the medium‑term view favors a buy on fundamentals, and the long‑term outlook recommends a cautious hold pending valuation compression.
Market Outlook
Short Term
< 1 yearKey Factors
- price above support but below resistance
- neutral RSI and bearish MACD
- increasing volume indicating momentum
Medium Term
1–3 yearsKey Factors
- strong margin profile and revenue growth
- forward PE still high but improving
- robust operating cash flow
Long Term
> 3 yearsKey Factors
- significant overvaluation relative to industry
- high leverage and beta increasing systematic risk
- potential for valuation compression as market normalises
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.